Marshall Wace LLP Has $671,000 Stock Position in FibroGen, Inc. (NASDAQ:FGEN)
Marshall Wace LLP lessened its stake in FibroGen, Inc. (NASDAQ:FGEN – Free Report) by 12.4% in the fourth quarter, Holdings Channel reports. The firm owned 1,265,515 shares of the biopharmaceutical company’s stock after selling 179,327 shares during the quarter. Marshall Wace LLP’s holdings in FibroGen were worth $671,000 at the end of the most recent […]
